Overview
To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions
Status:
Completed
Completed
Trial end date:
2004-06-01
2004-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To demonstrate the relative bioavailability of Cefzil 250 mg/5 ml oral suspension fed conditions.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
SandozTreatments:
Cefprozil
Cephalosporins
Criteria
Inclusion Criteria:- No clinically significant abnormal finding on physical exam, medical history, or
clinical laboratory results on screening.
Exclusion Criteria:
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.